Apigenin alleviates resistance to doxorubicin in breast cancer cells by acting on the JAK/STAT signaling pathway
Marwah Suliman MaashiMedical Laboratory Science Department, Faculty of Applied Medical Sciences, King Abdulaziz University, 21589, Jeddah, Saudi ArabiaMahmood Al-MualmDepartment of Clinical Laboratory Techniques, Al-Nisour University College, Baghdad, IraqGhaidaa Raheem Lateef Al‐AwsiMaria Jade Catalan OpulenciaCollege of Business Administration, Ajman University, Ajman, United Arab EmiratesMoaed E. Al‐GazallyCollege of Medicine, University of Al-Ameed, Karbala, IraqBekhzod AbdullaevDepartment of Science and Innovation, AKFA University, Tashkent, UzbekistanWalid Kamal AbdelbassetDepartment of Health and Rehabilitation Sciences, College of Applied Medical Sciences, Prince Sattam Bin Abdulaziz University, Al Kharj, Saudi ArabiaMohammad Javed AnsariDepartment of Pharmaceutics, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-kharj, Saudi ArabiaAbduladheem Turki JalilMedical Laboratories Techniques Department, Al-Mustaqbal University College, Babylon, Hilla, Iraq. [email protected]Fahad AlsaikhanDepartment of Clinical Pharmacy, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Alkharj, Kingdom of Saudi ArabiaMohammed Nader ShalabyBiological Sciences and Sports Health Department, Faculty of Physical Education, Suez Canal University, Ismailia, EgyptYasser Fakri MustafaDepartment of Pharmaceutical Chemistry, College of Pharmacy, University of Mosul, Mosul, Iraq
ABI
Abstract
No abstract available.
Topics
Identifiers
Citations and references
Cited by 030 references
Metrics — AkademScholar · Coming soon